UNIVERSITY OF PENNSYLVANIA
Therapeutic vaccination to boost autologous neutralizing antibodies for ART free HIV Control
Therapeutic vaccination to boost autologous neutralizing antibodies for ART free HIV Control is a funding opportunity from UNIVERSITY OF PENNSYLVANIA, up to 891410, closing July 31, 2030.
Jul 31, 2030
(1461d left)Overview
Summary Antibody-based approaches to HIV cure or ART-free remission hold promise. Several antibody-based therapeutic HIV vaccine trials are currently underway, leveraging germline-targeting approaches originally developed for HIV prevention, which ignore the existing autologous neutralizing antibody (anAb) responses…